NCT04882111: ALIGN Intervention in Patients With Advanced Cancer Discharging to a SNF

Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Early Phase 1
Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: 
Additional Notes: Patients must be discharging from a metro Detroit area hospital with hospice as their goal of care

Comments are closed.

Up ↑